Real-time enrollment status for this acute myeloid leukemia post cytotoxic therapy clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:03 PM UTC
| NCT Number | NCT07012044 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia Post Cytotoxic Therapy |
| Phase | PHASE1 |
| Target Enrollment | 47 participants |
| Active Locations | 13 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07012044 is currently recruiting participants. This phase1 study for acute myeloid leukemia post cytotoxic therapy is actively seeking new participants at 13 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07012044 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07012044 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.